Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financial Advisor

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Sep 20, 2023 5:13pm

194 Views

Post# 35646214

RE:RE:RE:Financial Advisor

CAinPlap: I was thinking about the FDAs Frontrunner program where a promising therapy could be potentially used upstream of where the trials are focused, in our case, post-BCG today. I don't know if that program has been successfully used anywhere. Yes, it could mean a separate set of phases. Don't know enough about it.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Jan. 10, 2025)